Click on the subcategory below to find drug monographs for that particular area.
Alcon announced the FDA approval of Simbrinza Suspension, a new beta-blocker-free, fixed-combination therapy for patients with glaucoma.
Adding carotenoids, omega-3 fatty acids, or both to an antioxidant formulation of vitamins and minerals previously shown to be effective in reducing the risk of progression to advanced age-related macular degeneration (AMD) does not further lower the risk.
The FDA has approved Abbott's Tecnis Toric 1-piece intraocular lens for the visual correction of aphakia and pre-existing corneal astigmatism. The Tecnis Toric lenses are indicated in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification.
Make prescribing decisions with our charts and treatment algorithms.
